Drug Profile
NPB 06
Alternative Names: NPB-06Latest Information Update: 14 Nov 2017
Price :
$50
*
At a glance
- Originator Nihon Pharmaceutical
- Class
- Mechanism of Action Blood coagulation factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Venous thrombosis
Most Recent Events
- 20 Oct 2017 NPB 06 is still undergoing phase III development for Venous thrombosis in Japan
- 20 Oct 2017 Efficacy data from a phase III trial in Venous thrombosis presented at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2017)
- 31 Mar 2017 No recent reports of development identified - Phase-III for Venous thrombosis in Japan (IV)